Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
1950 3
1952 1
1957 2
1958 2
1959 2
1960 1
1963 1
1964 7
1965 4
1966 3
1967 5
1968 2
1969 4
1970 4
1971 5
1972 4
1973 7
1974 14
1975 12
1976 8
1977 6
1978 1
1979 1
1980 5
1981 2
1982 4
1983 5
1984 7
1985 10
1986 7
1987 10
1988 14
1989 13
1990 8
1991 11
1992 15
1993 22
1994 23
1995 34
1996 37
1997 31
1998 23
1999 58
2000 62
2001 75
2002 71
2003 80
2004 92
2005 104
2006 125
2007 141
2008 166
2009 176
2010 225
2011 218
2012 202
2013 236
2014 257
2015 314
2016 289
2017 314
2018 293
2019 324
2020 367
2021 449
2022 468
2023 350
2024 422
2025 432
2026 212

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,159 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial.
Yau T, Galle PR, Decaens T, Sangro B, Qin S, da Fonseca LG, Karachiwala H, Blanc JF, Park JW, Gane E, Pinter M, Peña AM, Ikeda M, Tai D, Santoro A, Pizarro G, Chiu CF, Schenker M, He A, Chon HJ, Wojcik-Tomaszewska J, Verset G, Wang QQ, Stromko C, Neely J, Singh P, Jimenez Exposito MJ, Kudo M; CheckMate 9DW investigators. Yau T, et al. Among authors: chiu cf. Lancet. 2025 May 24;405(10492):1851-1864. doi: 10.1016/S0140-6736(25)00403-9. Epub 2025 May 8. Lancet. 2025. PMID: 40349714 Free article. Clinical Trial.
Body-wide multi-omic counteraction of aging with GLP-1R agonism.
Huang J, Kwok AJ, Li JCY, Chiu CLH, Ip BY, Tung LY, Chan RCH, Chan DCW, Wang Z, Zheng X, Chow HT, Lo MPS, Li Z, Lin N, Wang M, Yan LYC, Wu WKK, Chow KH, Lin WJ, Tang Y, Zhang Y, Song W, Ng BW, Wong SH, Leung TW, Mok VCT, Ko H. Huang J, et al. Among authors: chiu clh. Cell Metab. 2025 Dec 2;37(12):2362-2380.e8. doi: 10.1016/j.cmet.2025.10.014. Epub 2025 Nov 19. Cell Metab. 2025. PMID: 41265449 Free article.
ABCA7 variants impact phosphatidylcholine and mitochondria in neurons.
von Maydell D, Wright SE, Pao PC, Staab C, King O, Spitaleri A, Bonner JM, Liu L, Yu CJ, Chiu CC, Leible D, Ni Scannail A, Li M, Boix CA, Mathys H, Leclerc G, Menchaca GS, Welch G, Graziosi A, Leary N, Samaan G, Kellis M, Tsai LH. von Maydell D, et al. Among authors: chiu cc. Nature. 2025 Nov;647(8089):462-471. doi: 10.1038/s41586-025-09520-y. Epub 2025 Sep 10. Nature. 2025. PMID: 40931065 Free PMC article.
Plasma signals of lung tumor promotion for molecular cancer prevention.
Pandya T, Zagorulya M, Leung MM, Augustine M, Liu LY, Leppä AM, Baruchel U, Ng SW, Klockner T, Mugabo M, Griffen AJ, Blyuss O, Iliakis CS, Grenov A, Haase K, Muller DC, Chan KH, Wu J, Burk VA, Wright N, Le Marois A, Pazukhina E, Ward S, Slawinski H, Pelletier M, Murphy C, Park MD, Snoeks T, Suarez-Bonnet A, Priestnall SL, Chardas A, Grieco C, Archer A, Celik A, Jimenez-Sanchez A, Scott R, Zahed H, Montégut L, Meza R, Durney CH, Lam S, Karasaki T, Vermeulen RCH, Xu H, Serrano-Fernandez P, Crnogorac-Jurcevic T, Menon U, Apostolidou S, Zaikin A, Gunu R, Whitwell HJ, Huang Z, Li Z, Hu X, Zhu B, Li L, Chirlaque MD, Guevara M, Kolijn PM, Guenoun A, Mookherjee N, Johansson M, Wang Z, Chatterjee N, Chiu CH, Chen Z, Pe'er D, Sahai E, Freytag S, Wack A, Gunter MJ, Merad M, Zhang J, Carlsten C, Yang PC, Chen HY, Platz EA, LaFave LM, Smith-Byrne K, Jamal-Hanjani M, Litchfield K, Nene NR, McGranahan N, Grönroos E, Hill W, Weeden CE, Swanton C. Pandya T, et al. Among authors: chiu ch. Cell. 2026 Jun 25;189(13):3903-3921.e26. doi: 10.1016/j.cell.2026.05.005. Epub 2026 Jun 4. Cell. 2026. PMID: 42242224 Free article.
The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies.
Yang HC, Kwok PY, Li LH, Liu YM, Jong YJ, Lee KY, Wang DW, Tsai MF, Yang JH, Chen CH, Yeh EC, Wei CY, Fann CS, Huang YT, Chen CW, Lee YJ, Chu SK, Ho CH, Yang CS, Lee YL, Chen HH, Hou MC, Chiou JF, Yang SF, Wang CH, Huang CY, Chiu KM, Chen M, Chiang FT, Lee SL, Chen SS, Yao WJ, Chien CC, Lin SY, Chang FP, Ho HL, Yeh YC, Tseng WC, Lin MH, Chang HT, Tseng LM, Liang WY, Chen PC, Hang JF, Lin SC, Chan YJ, Kuo YJ, Wang LC, Pan CC, Hsieh YC, Chen YM, Hsiao TH, Lin CH, Chen YJ, Chen IC, Mao CL, Chang SJ, Chang YL, Liao YJ, Lai CH, Lee WJ, Tung H, Yen TT, Yen HC, Shih CM, Chou TY, Liou TH, Chiang CY, Cherng YG, Chen CH, Chiu CH, Tseng SH, Lin EP, Chen YJ, Chuang HP, Chen TC, Huang WT, Sin J, Liu IL, Chen YC, Chao KK, Wu YM, Yu PP, Chang LP, Yen KY, Chang LC, Sheen YJ, Chen YT, Kan K, Tsai HL, Wang YK, Hou MF, Yang YH, Kuo CH, Wu WJ, Huang JF, Chong IW, Tsai JR, Lin CY, Yu MC, Lee TH, Tsai MH, Ou YC, Chen PY, Hu TH, Shyu YC, Cheng CK, Fang YJ, Hsieh SC, Chen CH, Chen CC, Li KJ, Lin CH, Chiu HY, Wu CC, Chen CY, Chu SJ, Liu FC, Yang FC, Chang HA, Chen WL, Yang SS, Sung YF, Wang TF, Lin SZ, Wu YW, Wu CS, Jiang JY, Ma GC, Chang TY, Hwang JJ, Kao KJ, Hung CF, Chiu TF, Chen PY, Tsui K, Wu … See abstract for full author list ➔ Yang HC, et al. Among authors: chiu ch. Nature. 2025 Dec;648(8092):117-127. doi: 10.1038/s41586-025-09680-x. Epub 2025 Oct 15. Nature. 2025. PMID: 41092961 Free PMC article.
Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration.
Lin YJ, Ou DL, Su YY, Hsu CL, Hsiao CF, Ko BS, Chen SC, Wang HW, Wang JH, Wu YM, Jeng YM, Lee WC, Chou SC, Chen TW, Chiu CF, Lin JS, Hsieh CH, Lee CC, Shan YS, Cheng AL, Chen LT, Hsu C. Lin YJ, et al. Among authors: chiu cf. J Hepatol. 2026 Feb;84(2):316-328. doi: 10.1016/j.jhep.2025.08.035. Epub 2025 Sep 17. J Hepatol. 2026. PMID: 40972843 Free article. Clinical Trial.
First-Line Lorlatinib Versus Crizotinib in Asian Patients With Advanced ALK-Positive NSCLC: Five-Year Outcomes From the CROWN Study.
Wu YL, Kim HR, Soo RA, Zhou Q, Akamatsu H, Chang GC, Chiu CH, Hayashi H, Kim SW, Goto Y, Kato T, Zhou J, Lee VH, Nishio M, Han B, Kim DW, Lu S, Polli A, Martini JF, Toffalorio F, Wong CH, Mok T. Wu YL, et al. Among authors: chiu ch. J Thorac Oncol. 2025 Jul;20(7):955-968. doi: 10.1016/j.jtho.2025.02.021. Epub 2025 Feb 28. J Thorac Oncol. 2025. PMID: 40024442 Free article. Clinical Trial.
Vascular-Perfusable Human 3D Brain-on-Chip.
Stanton AE, Pinals RL, Choi A, Truong N, Kang E, Jiang A, Lozano Cruz CF, Hawkins S, Sarcar R, Volkova A, King O, Agbas E, Nakano M, Chiu CC, Bubnys A, Wright S, Staab C, Bikdash R, Forden E, Langer R, Tsai LH. Stanton AE, et al. Among authors: chiu cc. bioRxiv [Preprint]. 2025 Sep 25:2025.09.18.676925. doi: 10.1101/2025.09.18.676925. bioRxiv. 2025. PMID: 41000798 Free PMC article. Preprint.
LRRK2 kinase activity regulates Parkinson's disease-relevant lipids at the lysosome.
Maloney MT, Wang X, Ghosh R, Andrews SV, Maciuca R, Masoud ST, Agam M, Caprioli RM, Astarita G, Bondar VV, Chen J, Chiu CL, Davis SS, Ho AC, Nguyen HN, Propson NE, Reyzer ML, Davis OB, Deen MC, Zhu S, Di Paolo G, Vocadlo DJ, Estrada AA, de Vicente J, Lewcock JW, Arguello A, Suh JH, Huntwork-Rodriguez S, Henry AG. Maloney MT, et al. Among authors: chiu cl. Mol Neurodegener. 2025 Aug 6;20(1):89. doi: 10.1186/s13024-025-00880-7. Mol Neurodegener. 2025. PMID: 40770658 Free PMC article.
6,159 results